Neroes

Neroes operates at the intersection of neurotechnology, sports performance, digital health, and medical devices. Its differentiation is the combination of EEG-based brain monitoring, adaptive neurofeedback algorithms, and interactive gaming rather than a standalone wearable or conventional mental-wellness application. The company targets athletes with training intended to improve stress management, emotional control, and performance, while its Corporate Solutions product broadens the potential market to workplace wellbeing. Relative to general fitness wearables, Neroes emphasizes brain-state feedback and active cognitive training; relative to clinical neurotechnology providers, its product framing is more performance- and engagement-oriented. The company’s disclosed $250,955 in funding and team size of fewer than 10 employees indicate an early-stage position, with validation and commercialization scale not publicly documented.

Neroes was founded in 2019 and recorded its first disclosed financing on Jan 29, 2021, a $955 Pre-Seed round from Portugal Ventures. The company then reached a more meaningful financing milestone on Sep 1, 2022 with a $250,000 Pre-Seed round involving Newchip Accelerator and Draper Startup House Ventures. That progression suggests a move from early formation toward product development and investor-backed commercialization, although no later financing is documented. The platform’s evolution appears to include two routes to market: an athlete-focused mental training product and Corporate Solutions for employee performance and wellbeing. The core technical inflection point is the integration of wearable brain-wave sensing with an adaptive videogame, enabling real-time neurofeedback rather than static content delivery. Neroes currently has two featured employees and an estimated workforce of fewer than 10 people.